Compound α-Ketoacid Tablets

Compound alpha-Ketoacid Tablets (630 mg/tablet, ketoanalogues, CAS 51828-95-6) are manufactured directly by Nanjing Lifenergy R&D Co., Ltd. to Chinese Pharmacopoeia (ChP) standards. They are indicated for the prevention and treatment of protein-metabolism damage in chronic renal insufficiency, used alongside a limited protein diet of 40 g per day or less, generally in patients with a glomerular filtration rate below 25 ml/min. The manufacturer distributes the tablets globally, though samples are not offered.